
Incellvu S.A.
Research and experimental development in natural sciences and engineering
Overview
Incellvu is a company that develops innovative devices for ultra-fast volumetric imaging of the cellular structure of the human retina in vivo. They aim to create an optical coherence tomography (OCT) system for non-invasive imaging of the eye's structure and function with microscopic resolution, supporting the diagnosis of eye diseases and gene therapies to prevent vision loss. Their technology, known as spatio-temporal optical coherence tomography (STOC-T), allows for high-resolution imaging and functional analysis of the retina.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
Financial statements were filed on time, on average 17 days early. All were audited by a statutory auditor.
- 202530/06/2026
- 202426/06/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Optical tomograph
- Retinal imaging device
- Photoreceptor analysis
- Eye imaging
- Image analysis
Websites
- incellvu.plInCellVu – Nano-cellular Revolution in OphthalmologyApache
Authorized Representatives
Manner of representation
One member of the management board acting independently is authorized to make declarations of will and sign on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-08-01.
55 1090 2590 0000 0001 4651 4597
96 1090 1883 0000 0001 6688 7826
82 1090 2590 0000 0001 4651 4596
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 7, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,582$2,582 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Digital Pathology Team sp. z o.o. | $64,552.91 | digitalpathologyteam.com | ||
| Incepton sp. z o.o. | $26,312.86 | incepton.com | ||
| Smart Tracking sp. z o.o. | $25,615.27 | smarttracking.pl | ||
| Muotech sp. z o.o. | $21,191.78 | muotech.io | ||
| Igness sp. z o.o. | $18,775.94 | igness.com | ||
| Antmicro Research sp. z o.o. | $12,054.32 | antmicro.com | ||
| Skinai sp. z o.o. | $11,914.59 | skinai.pl | ||
| DSQ Tech sp. z o.o. | $5,026.69 | dsqtech.pl | ||
| Microanalysis sp. z o.o. | $1,425.98 | microanalysis.pl | ||
| Uplogic sp. z o.o. | $1,262.05 | uplogic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-10 | Share capital increase (2,706,050.00 PLN → 3,306,050.00 PLN) | |
| 2025-02-25 | Address change (Ul. Skierniewicka 16/20, 01-230, Warszawa → Ul. Skierniewicka 10a, 01-230, Warszawa) | |
| 2025-02-25 | Share capital increase (2,615,050.00 PLN → 2,706,050.00 PLN) | |
| 2025-02-24 | Switch to PKD 2025 (5 PKD 2007 codes → 5 PKD 2025 codes) | |
| 2024-05-29 | Share capital increase (2,175,050.00 PLN → 2,615,050.00 PLN) |
FAQ
Last updated: 2026-07-02